When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Which cardiovascular drugs may help lower dementia risk? - AOL

   www.aol.com/cardiovascular-drugs-may-help-lower...

   Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications ...

3. Heart diseases raise dementia risk: Could a common blood ...

   www.aol.com/heart-diseases-raise-dementia-risk...

   AFib, the most common heart rhythm disorder, is linked to a 39% increased risk of cognitive impairment, while coronary heart disease increases the risk of dementia by 27%, with up to 50% of heart ...

4. Valsartan - Wikipedia

   en.wikipedia.org/wiki/Valsartan

   Valsartan is combined with amlodipine or hydrochlorothiazide (HCTZ) (or both) into single-pill formulations for treating hypertension with multiple drugs. [8] [41] [42] [43] Valsartan is also available as the combination valsartan/sacubitril. [40] [44] [45] It is used to treat heart failure with reduced ejection fraction. [45] [46]

5. Sacubitril/valsartan - Wikipedia

   en.wikipedia.org/wiki/Sacubitril/valsartan

   Another 2015 review called the reductions in mortality and hospitalization conferred by sacubitril/valsartan "striking", but noted that its effects in heart failure people with hypertension, diabetes, chronic kidney disease, and the elderly needed to be evaluated further.

6. Widely-used heart drug linked to increased dementia risk - AOL

   www.aol.com/article/2016/05/06/heart-drug...

   Patients on the blood-thinning drug Warfarin experienced higher rates of dementia and Alzheimer's, according to a new study. Widely-used heart drug linked to increased dementia risk Skip to main ...

7. Angiotensin II receptor blocker - Wikipedia

   en.wikipedia.org/wiki/Angiotensin_II_receptor...

   [citation needed] More recently, they have been used for the treatment of heart failure in patients intolerant of ACE inhibitor therapy, in particular candesartan. Irbesartan and losartan have trial data showing benefit in hypertensive patients with type 2 diabetes, [citation needed] and may delay the progression of diabetic nephropathy.